International multicenter cohort study on beta-blocker-free treatment strategies for catecholaminergic polymorphic ventricular tachycardia patients: ventricular tacchycardia
Background - Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a rare, potentially life-threatening genetic heart disease. Nonselective beta-blockers (BBs) are highly effective in reducing CPVT-triggered arrhythmic events. However, some patients suffer from unacceptable BB side effects...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
February 2025
|
| In: |
JACC Clinical electrophysiology
Year: 2025, Volume: 11, Issue: 2, Pages: 270-278 |
| ISSN: | 2405-5018 |
| DOI: | 10.1016/j.jacep.2024.10.005 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.jacep.2024.10.005 Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S2405500X24008697 
|
| Author Notes: | Raquel Neves, MD, Sahej Bains, BS, J. Martijn Bos, MD, P HD, Christian van der Werf, MD, PH D, Auke T. Bergeman, MD, Puck Peltenburg, MD, Nico A. Blom, MD, P HD, Shubhayan Sanatani, MD, Heikki Swan, MD, Vincent Probst, MD, Prince J. Kannankeril, MD, MSCI, Jonathan R. Skinner, MD, Ramon Brugada, MD, Tomas Robyns, MD, Martin Borggrefe, MD, Wataru Shimizu, MD, P HD, Janneke A.E. Kammeraad, MD, PH D, Andrew D. Krahn, MD, Arthur A.M. Wilde, MD, P HD, Michael J. Ackerman, MD, PHD |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1930989318 | ||
| 003 | DE-627 | ||
| 005 | 20250913141732.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 250717s2025 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jacep.2024.10.005 |2 doi | |
| 035 | |a (DE-627)1930989318 | ||
| 035 | |a (DE-599)KXP1930989318 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Neves, Raquel |e VerfasserIn |0 (DE-588)1371721262 |0 (DE-627)1930991045 |4 aut | |
| 245 | 1 | 0 | |a International multicenter cohort study on beta-blocker-free treatment strategies for catecholaminergic polymorphic ventricular tachycardia patients |b ventricular tacchycardia |c Raquel Neves, MD, Sahej Bains, BS, J. Martijn Bos, MD, P HD, Christian van der Werf, MD, PH D, Auke T. Bergeman, MD, Puck Peltenburg, MD, Nico A. Blom, MD, P HD, Shubhayan Sanatani, MD, Heikki Swan, MD, Vincent Probst, MD, Prince J. Kannankeril, MD, MSCI, Jonathan R. Skinner, MD, Ramon Brugada, MD, Tomas Robyns, MD, Martin Borggrefe, MD, Wataru Shimizu, MD, P HD, Janneke A.E. Kammeraad, MD, PH D, Andrew D. Krahn, MD, Arthur A.M. Wilde, MD, P HD, Michael J. Ackerman, MD, PHD |
| 264 | 1 | |c February 2025 | |
| 300 | |b Illustrationen, Diagramme | ||
| 300 | |a 9 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Online verfügbar: 18. Dezember 2024, Artikelversion: 24. Februar 2025 | ||
| 500 | |a Gesehen am 17.07.2025 | ||
| 520 | |a Background - Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a rare, potentially life-threatening genetic heart disease. Nonselective beta-blockers (BBs) are highly effective in reducing CPVT-triggered arrhythmic events. However, some patients suffer from unacceptable BB side effects and might require strategies without a BB. - Objectives - This study sought to review the spectrum of and outcomes associated with BB-free treatment configurations in patients with CPVT enrolled in the International CPVT Registry. - Methods - From the Registry, patients with RYR2 variant-positive CPVT treated with a BB-free strategy for ≥6 months were included. Two treatment groups were defined: patients classified as very low risk and treated with intentional nontherapy (INT) and patients who needed to be treated but did not tolerate BBs and were treated with 3 different strategies. - Results - Overall, 100 of 1,017 patients (10%) were on a BB-free treatment strategy. There were 73 patients (33 females [42%]) in the INT group. In patients 66 (90%), INT was pursued after low-risk assessment in asymptomatic patients and absent or negligible stress test phenotype. Twenty-seven patients (22 females, 81%) were treated using 3 different BB-free treatment strategies (flecainide monotherapy, n = 21; left cardiac sympathetic denervation monotherapy, n = 2; flecainide + left cardiac sympathetic denervation, n = 4). In total, 25 patients (93%) were previously treated with BBs. During a median follow-up of 6 years (IQR: 3-9 years), 2 patients (2%) had a CPVT-associated event. - Conclusions - Although nonselective BBs remain the cornerstone treatment for CPVT, 10% of patients with CPVT required a BB-free treatment strategy. After careful risk assessment, safe and effective BB-free treatment strategies can be configured. | ||
| 650 | 4 | |a Beta-blockers | |
| 650 | 4 | |a CPVT | |
| 650 | 4 | |a side effects | |
| 700 | 1 | |a Bains, Sahej |e VerfasserIn |4 aut | |
| 700 | 1 | |a Bos, J. Martijn |e VerfasserIn |4 aut | |
| 700 | 1 | |a van der Werf, Christian |e VerfasserIn |4 aut | |
| 700 | 1 | |a Bergeman, Auke T. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Peltenburg, Puck |e VerfasserIn |4 aut | |
| 700 | 1 | |a Blom, Nico A. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Sanatani, Shubhayan |e VerfasserIn |4 aut | |
| 700 | 1 | |a Swan, Heikki |e VerfasserIn |4 aut | |
| 700 | 1 | |a Probst, Vincent |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kannankeril, Prince J. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Skinner, Jonathan R. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Brugada, Ramon |e VerfasserIn |4 aut | |
| 700 | 1 | |a Robyns, Tomas |e VerfasserIn |4 aut | |
| 700 | 1 | |a Borggrefe, Martin |e VerfasserIn |0 (DE-588)1025920546 |0 (DE-627)725574232 |0 (DE-576)370913426 |4 aut | |
| 700 | 1 | |a Shimizu, Wataru |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kammeraad, Janneke A. E. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Krahn, Andrew D. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Wilde, Arthur A. M. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ackerman, Michael J. |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t JACC Clinical electrophysiology |d Amsterdam : Elsevier, 2015 |g 11(2025), 2 vom: Feb., Seite 270-278 |h Online-Ressource |w (DE-627)84750347X |w (DE-600)2846739-5 |w (DE-576)455431868 |x 2405-5018 |7 nnas |a International multicenter cohort study on beta-blocker-free treatment strategies for catecholaminergic polymorphic ventricular tachycardia patients ventricular tacchycardia |
| 773 | 1 | 8 | |g volume:11 |g year:2025 |g number:2 |g month:02 |g pages:270-278 |g extent:9 |a International multicenter cohort study on beta-blocker-free treatment strategies for catecholaminergic polymorphic ventricular tachycardia patients ventricular tacchycardia |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.jacep.2024.10.005 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.sciencedirect.com/science/article/pii/S2405500X24008697 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20250717 | ||
| 993 | |a Article | ||
| 994 | |a 2025 | ||
| 998 | |g 1025920546 |a Borggrefe, Martin |m 1025920546:Borggrefe, Martin |d 60000 |d 61000 |e 60000PB1025920546 |e 61000PB1025920546 |k 0/60000/ |k 1/60000/61000/ |p 15 | ||
| 999 | |a KXP-PPN1930989318 |e 4747148043 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"name":{"displayForm":["Raquel Neves, MD, Sahej Bains, BS, J. Martijn Bos, MD, P HD, Christian van der Werf, MD, PH D, Auke T. Bergeman, MD, Puck Peltenburg, MD, Nico A. Blom, MD, P HD, Shubhayan Sanatani, MD, Heikki Swan, MD, Vincent Probst, MD, Prince J. Kannankeril, MD, MSCI, Jonathan R. Skinner, MD, Ramon Brugada, MD, Tomas Robyns, MD, Martin Borggrefe, MD, Wataru Shimizu, MD, P HD, Janneke A.E. Kammeraad, MD, PH D, Andrew D. Krahn, MD, Arthur A.M. Wilde, MD, P HD, Michael J. Ackerman, MD, PHD"]},"id":{"doi":["10.1016/j.jacep.2024.10.005"],"eki":["1930989318"]},"physDesc":[{"noteIll":"Illustrationen, Diagramme","extent":"9 S."}],"recId":"1930989318","relHost":[{"disp":"International multicenter cohort study on beta-blocker-free treatment strategies for catecholaminergic polymorphic ventricular tachycardia patients ventricular tacchycardiaJACC Clinical electrophysiology","recId":"84750347X","physDesc":[{"extent":"Online-Ressource"}],"id":{"eki":["84750347X"],"issn":["2405-5018"],"zdb":["2846739-5"]},"title":[{"title":"JACC Clinical electrophysiology","title_sort":"JACC Clinical electrophysiology","subtitle":"a journal of the American College of Cardiology"}],"part":{"volume":"11","year":"2025","text":"11(2025), 2 vom: Feb., Seite 270-278","extent":"9","issue":"2","pages":"270-278"},"type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"note":["Gesehen am 12. Februar 2016"],"origin":[{"publisher":"Elsevier","dateIssuedDisp":"2015-","dateIssuedKey":"2015","publisherPlace":"Amsterdam"}],"pubHistory":["Volume 1, number 1-2 (March/April 2015)-"]}],"person":[{"display":"Neves, Raquel","given":"Raquel","role":"aut","family":"Neves"},{"family":"Bains","given":"Sahej","role":"aut","display":"Bains, Sahej"},{"given":"J. Martijn","role":"aut","family":"Bos","display":"Bos, J. Martijn"},{"family":"van der Werf","given":"Christian","role":"aut","display":"van der Werf, Christian"},{"family":"Bergeman","given":"Auke T.","role":"aut","display":"Bergeman, Auke T."},{"family":"Peltenburg","given":"Puck","role":"aut","display":"Peltenburg, Puck"},{"given":"Nico A.","role":"aut","family":"Blom","display":"Blom, Nico A."},{"family":"Sanatani","given":"Shubhayan","role":"aut","display":"Sanatani, Shubhayan"},{"family":"Swan","given":"Heikki","role":"aut","display":"Swan, Heikki"},{"display":"Probst, Vincent","role":"aut","given":"Vincent","family":"Probst"},{"display":"Kannankeril, Prince J.","role":"aut","given":"Prince J.","family":"Kannankeril"},{"display":"Skinner, Jonathan R.","role":"aut","given":"Jonathan R.","family":"Skinner"},{"display":"Brugada, Ramon","family":"Brugada","role":"aut","given":"Ramon"},{"display":"Robyns, Tomas","role":"aut","given":"Tomas","family":"Robyns"},{"display":"Borggrefe, Martin","role":"aut","given":"Martin","family":"Borggrefe"},{"display":"Shimizu, Wataru","role":"aut","given":"Wataru","family":"Shimizu"},{"display":"Kammeraad, Janneke A. E.","family":"Kammeraad","given":"Janneke A. E.","role":"aut"},{"display":"Krahn, Andrew D.","given":"Andrew D.","role":"aut","family":"Krahn"},{"display":"Wilde, Arthur A. M.","family":"Wilde","role":"aut","given":"Arthur A. M."},{"display":"Ackerman, Michael J.","family":"Ackerman","given":"Michael J.","role":"aut"}],"origin":[{"dateIssuedKey":"2025","dateIssuedDisp":"February 2025"}],"note":["Online verfügbar: 18. Dezember 2024, Artikelversion: 24. Februar 2025","Gesehen am 17.07.2025"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"title":[{"subtitle":"ventricular tacchycardia","title":"International multicenter cohort study on beta-blocker-free treatment strategies for catecholaminergic polymorphic ventricular tachycardia patients","title_sort":"International multicenter cohort study on beta-blocker-free treatment strategies for catecholaminergic polymorphic ventricular tachycardia patients"}]} | ||
| SRT | |a NEVESRAQUEINTERNATIO2025 | ||